INTERNATIONAL PATENT: PRELUDE THERAPEUTICS INCORPORATED, SHVARTSBART, ARTEM FILES APPLICATION FOR "BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE"

GENEVA, May 19 -- PRELUDE THERAPEUTICS INCORPORATED (175 Innovation BoulevardWilmington, Delaware 19805), SHVARTSBART, Artem (105 Quail LaneKennett Square, Pennsylvania 19348) filed a patent application (PCT/US2024/054907) for "BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE" on Nov 07, 2024. With publication no. WO/2025/101738, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEVANNAH, Vijayarajan (1709 Mel LaneNewark, Delaware 19713), BASCH, Corey Howard (14456 Oak Branch RoadDelmar, Delaware 19949), ROSE, John A. ...